Simpson, Eric L. http://orcid.org/0000-0003-0853-0252
de Bruin-Weller, Marjolein
Bansal, Ashish
Chen, Zhen
Nelson, Lauren
Whalley, Diane
Prescilla, Randy
Guillemin, Isabelle
Delevry, Dimittri
Clinical trials referenced in this document:
Documents that mention this clinical trial
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial
https://doi.org/10.1007/s40257-023-00791-7
Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis
https://doi.org/10.1007/s13555-021-00543-7
Funding for this research was provided by:
Regeneron Pharmaceuticals
Article History
Received: 1 March 2021
First Online: 27 May 2021